# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Thomas Jefferson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN005-SYN-TD
- Date: 1790-05-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Nathaniel Beaumont-Ruiz, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review of the headache diary, seen the same day by headache medicine. **S**

## History of present illness

Mr. Jefferson returns with his 14-day headache diary and is seen by Dr. Haddad of headache medicine on the same day. The bout that began three weeks ago has eased. His diary shows headache on 7 of 14 days: each attack began between nine and ten in the morning, built over an hour to a moderate or severe throbbing pain across the forehead and temples, worse with reading and climbing stairs, with sensitivity to light and noise on every headache day and nausea on four, and lasted six to ten hours, settling by evening. He had no visual or other aura. The last seven days have been headache-free. He took naproxen on four days, with metoclopramide on two, and the pain was reduced but rarely gone after two hours; he has taken no combination analgesic since intake. Counting the week before intake, he has had 13 migraine days in the past four weeks. He has been sleeping six hours, has kept to two cups of coffee and has not skipped lunch. He has had no weakness, numbness, fever or change in vision. **S**

| Element | Detail |
|---|---|
| Diary | Headache on 7 of 14 days; morning onset, six to ten hours, throbbing, light and noise sensitivity, nausea on four days; no aura |
| Past four weeks | 13 migraine days |
| Acute medicine | Naproxen on four days, metoclopramide on two; partial relief |
| Combination analgesic | None since intake |
| Red flags | None |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight loss |
| Eyes | Negative | No visual aura or loss of vision |
| Neurological | Positive | Migraine attacks as in the diary; no weakness, numbness or speech change |
| Psychiatric | Negative | Frustrated by lost work; mood otherwise steady |

4 systems reviewed. **S**

## Current medications

- Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a week **S**
- Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a week **S**
- Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a month **S**
- Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine prevention **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 76.2 kg; BMI 21.3 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Comfortable today; blood pressure 122/78, pulse 70 |
| Eyes | Fundi with sharp discs; visual fields full |
| Neurological | Cranial nerves, strength, sensation, reflexes, coordination and gait normal |
| Head and neck | Mild tenderness of the neck and shoulder muscles; temporal arteries normal |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Migraine without aura, episodic, with bouts of near-daily attacks** (G43.009). Dr. Haddad confirms migraine without aura by ICHD-3 criteria: at least five attacks lasting 4 to 72 hours, of moderate to severe throbbing pain made worse by routine activity, with nausea and with light and noise sensitivity, and no better explanation. The long, stable history and normal examination without red flags mean no imaging is needed. With 13 migraine days in four weeks during bouts and a MIDAS of 39, preventive treatment is indicated. **S**
   - Sumatriptan 100 mg with naproxen 500 mg early in an attack, a second sumatriptan after two hours if needed.
   - Propranolol extended-release 80 mg each evening, to be raised to 120 mg at four weeks if tolerated.
   - Keep acute medicine to two days a week or fewer and record every dose in the diary.
2. **Stiff right wrist after an old dislocation** (M25.631). Writing remains slow and painful after an hour. **S**
   - Occupational therapy visit as planned; dictation software in the meantime.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Red-flag screen (SNNOOP10): systemic signs, neurological signs, sudden or new pattern, onset after 50, positional or Valsalva features, papilledema, progressive course | Every visit | Completed today | No red flags; normal neurological examination and fundi |
| Survey | Headache diary: headache and migraine days, attack features, triggers | Every visit | Completed today | 14 days kept: headache on the first 7 days, all meeting migraine features; 13 migraine days in the past four weeks |
| Medication safety | Acute-medicine days (medication overuse headache limits: triptan fewer than 10, NSAID fewer than 15 days a month) | Every visit | Completed today | Naproxen on four days in 14; no combination analgesic since intake |
| Medication safety | Acute treatment response (pain-free at two hours, return to work) | Every visit | Completed today | Naproxen gave partial relief, rarely pain-free at two hours; triptan added |
| Medication safety | Cardiovascular screen before a triptan | Before the first triptan prescription | Completed today | No chest pain, vascular disease, uncontrolled blood pressure or smoking; blood pressure 122/78 |
| Medication safety | Propranolol tolerability: pulse, blood pressure, tiredness, exercise tolerance, wheeze, cold hands, sleep | Four weeks after starting or changing the dose, then each visit | Completed today | Before starting: pulse 70, blood pressure 122/78; no asthma, heart block or depression |
| Examination | Preventive efficacy (at least 50% fewer migraine days) | At two to three months on an adequate dose | Due | Propranolol started today; efficacy judged at the three-month review |
| Survey | Disability (MIDAS, recorded as its five items, and HIT-6) | At baseline and after about three months of prevention | Up to date | MIDAS 39 (grade IV) and HIT-6 66 at intake; repeat at three months |
| Survey | Mood (PHQ-9) and anxiety (GAD-7), including on a beta-blocker | At baseline, four to six weeks after starting a preventive that can affect mood, then at each review | Up to date | PHQ-9 6 and GAD-7 7 at intake; repeat four to six weeks after starting propranolol |
| Imaging | Neuroimaging | Only for red flags or a change in pattern | Not indicated | Stable pattern for more than twenty years, normal examination, no red flags |
| Self-management | Sleep, meals, caffeine and work-stress plan | Every visit | Completed today | Six hours of sleep, two cups of coffee, regular lunch |
| Referral | Headache medicine consultation | At diagnosis | Completed today | Seen by Dr. Haddad today |
| Referral | Occupational therapy visit for the right wrist and writing | Within four weeks of intake | Ordered | Requested at intake; awaiting an appointment |

## Goal progress

- A two-week headache diary that allows a firm diagnosis. Outcome by 1790-05-21: Diary of 14 days kept; ICHD-3 criteria for migraine without aura met; no red flags. **S**
- Monthly migraine days reduced by at least half within three months of starting prevention. In progress; target 1790-08-13. **S**
- Acute medicine on no more than two days a week, so that medication overuse headache does not develop. In progress; target 1790-08-13. **S**
- Pain-free within two hours of acute treatment in most attacks. In progress; target 1790-08-13. **S**
- Lower headache-related disability. In progress; target 1790-08-13. **S**
- Write for longer without wrist pain. In progress; target 1790-08-13. **S**

## Medication changes

- Started: Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a month **S**
- Started: Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine prevention **S**

## Guideline basis

- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018), International Headache Society (Cephalalgia 2018;38(1):1-211)
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021), American Headache Society (Headache 2021;61(7):1021-1039)
- Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024), American Headache Society (Headache 2024;64(4):333-341)
- The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019), American Headache Society (Headache 2019;59(1):1-18)
- Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025), American College of Physicians (Annals of Internal Medicine 2025;178(4):571-578)
- Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025), American College of Physicians (Annals of Internal Medicine 2025;178(3):426-433)
- Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013), American Headache Society (Headache 2013;53(10):1651-1659)

## Follow-up

- Six-week review in four weeks. Diary continued. Call for a headache unlike his usual attacks, weakness, numbness, fever or a stiff neck. **S**
- Next scheduled visit 1790-06-18: six-week review, four weeks after starting propranolol: tolerability, attacks, acute medicine days and the wrist. **S**
